课题基金 / 基金详情

Mitochondrial TDP-43 in Alzheimer's Disease

Mitochondrial TDP-43 in Alzheimer's Disease
阿尔茨海默病中的线粒体 TDP-43
批准号:
10578054
负责人:
Xinglong Wang
金额:
$115.47万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-07-15 至 2022-10-18

项目摘要

项目成果

Xinglong Wang的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY Alzheimer's disease (AD) is the leading cause of dementia in the elderly, characterized by neurofibrillary tangles, senile plaques and a progressive loss of neuronal cells in neocortex and hippocampus. Currently, there is no effective treatment for AD. Genetic mutations in TAR DNA-binding protein 43 (TDP-43) cause amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD, the second most common form of early-onset dementia), and the increased presence of TDP-43 in the cytoplasm is a prominent histopathological feature of degenerating neurons in more than half of AD patients. Despite an expanding body of evidence suggests that TDP-43 may be “the third protein” playing a distinct role in the pathogenesis of AD or related dementia, in addition to amyloid beta (Aβ) and tau, the molecular pathomechanisms of TDP-43 remain elusive. Interestingly, in our preliminary studies, we found that TDP-43 became highly associated with mitochondria in AD patients, neurons treated with Aβ and APP/PS1 (5XFAD) transgenic mice for AD. Based on identified motifs critical for TDP-43 mitochondrial localization, our most recent study revealed that the suppression of TDP-43 mitochondrial localization was sufficient to prevent TDP-43-induced neuronal loss, and improve behavioral performances in TDP-43 transgenic mice, indicating mitochondria as important mediators for TDP-43 neurotoxicity. Excitingly, the inhibition of TDP-43 mitochondrial localization could significantly alleviate neuronal death and behavioral deficits in 5XFAD mice well after symptom onset. These exciting and promising preliminary studies suggest that a detailed investigation into the potential role of mitochondria- associated TDP-43 in AD and related dementia is warranted. Using both cultured neuronal and transgenic mouse models for AD and related dementia, this study will test the feasibility of targeting mitochondria- associated TDP-43 as a novel therapeutic approach for AD and related dementia. The increased presence of TDP-43 in the cytoplasm is a prominent common histopathological feature of degenerating neurons in various major neurodegenerative diseases including AD, FTD and ALS. Our proposed studies of mitochondria- associated TDP-43 and its connection with the generally believed AD culprit Aβ will have very broad scientific and translational significance.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mitochondrial modulation of neuroinflammation in AD and related tauopathies
  • 批准号:
    10766083
  • 项目类别:
  • 资助金额:
    $156.83万
  • 财政年份:
    2020
  • 负责人:
    Xinglong Wang
  • 依托单位:
Mitochondrial modulation of neuroinflammation in AD and related tauopathies
Mitochondrial TDP-43 in Alzheimer's Disease
  • 批准号:
    10766077
  • 项目类别:
  • 资助金额:
    $30.6万
  • 财政年份:
    2019
  • 负责人:
    Xinglong Wang
  • 依托单位:
Mitochondrial TDP-43 in Alzheimer's Disease
  • 批准号:
    9815609
  • 项目类别:
  • 资助金额:
    $54.89万
  • 财政年份:
    2019
  • 负责人:
    Xinglong Wang
  • 依托单位:
国内基金
海外基金
TDP43作为肝癌仑伐替尼耐药新靶点对肝 癌治疗的重要作用及机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2025
  • 负责人:
    周洪钟
  • 依托单位:
TDP-43通过CXCL10/CXCR3重塑星形胶质细胞-突触对话介导偏头痛认知障碍机制研究
  • 批准号:
    2025JJ60697
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    龚俏宇
  • 依托单位:
知母皂苷AⅢ靶向TDP-43激活cGAS/STING信号轴介导免疫原性细胞死亡发挥抗肿瘤免疫的分子机制研究
  • 批准号:
    2024A02018
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    李泽荣
  • 依托单位:
TDP-43 通过抑制线粒体自噬激活 mtDNA-cGAS/STING 通路调控细胞焦亡在慢 加急肝衰竭的机制研究
  • 批准号:
    Q24H030017
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    张晓倩
  • 依托单位: